Doç. Dr. Engin ALAGÖZ

1. PET/CT Imaging in Medullary Thyroid Cancer Medüller Tiroid Kanserinde PET/BT Görüntüleme

ALAGÖZ E.

Nuclear Medicine Seminars , cilt.12, sa.1, ss.43-53, 2026 (Scopus)

2. Impact of perinodal infiltration on recurrence in papillary thyroid cancer Impacto de la infiltración periganglionar en la recurrencia del carcinoma papilar de tiroides

Cinar A., Turan U., OKUYUCU K., Aydinbelge Dizdar N., Erol A., Bedi Alpay B., et al.

Revista Espanola de Medicina Nuclear e Imagen Molecular , cilt.45, sa.1, 2026 (SCI-Expanded, Scopus)

3. Evaluation of Various Forms of Sinusitis Using Bone Single-photon Emission Computed Tomography

Ulus Evecan S., Tosun F., ALAGÖZ E., Durmaz A., Ulus S., GEREK M.

Otorhinolaryngology Clinics , cilt.17, sa.3, ss.125-128, 2025 (Scopus)

4. Reliability and readability analysis of ChatGPT-4 and Google Bard as a patient information source for the most commonly applied radionuclide treatments in cancer patients Análisis de confiabilidad y lectibilidad de ChatGPT-4 y Google Gard como fuente de información del paciente para los tratamientos con radionúclidos más comúnmente aplicados en pacientes con cáncer

Şan H., Bayrakçi Ö., Çağdaş B., Serdengeçti M., ALAGÖZ E.

Revista Espanola de Medicina Nuclear e Imagen Molecular , cilt.43, sa.4, 2024 (SCI-Expanded, Scopus)

5. Clinical behaviour of papillary thyroid cancer oncocytic variant: Stage-matched comparison versus classical and tall cell variant papillary thyroid cancer Comportamiento clínico de la variante oncocítica del cáncer papilar de tiroides: comparación de su evolución frente al cáncer papilar, variantes clásica y de células altas

OKUYUCU K., İNCE S., ÇINAR A. S., San H., Samsum M., Dizdar N., et al.

Revista Espanola de Medicina Nuclear e Imagen Molecular , cilt.42, sa.2, ss.100-105, 2023 (SCI-Expanded, Scopus)

6. The Effects of CoronaVac (Sinovac) and BNT162b2 (BioNTech/ Pfizer) Vaccination on Oncologic18F-FDG PET/CT Studies CoronaVac (Sinovac) ve BNT162b2 (BioNTech/Pfizer) Aşılamasının Onkolojik18F-FDG PET/BT Çalışmalarına Etkileri

Şan H., ALAGÖZ E.

Molecular Imaging and Radionuclide Therapy , cilt.31, sa.3, ss.179-190, 2022 (Scopus, TRDizin)

7. DIAGNOSTIC PERFORMANCES OF 18F-FLUOROCHOLINE POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY AND REPEATED ULTRASONOGRAPHY IN DETECTING UNDEFINED LESIONS IN PATIENTS WITH AN INDICATION FOR PRIMARY HYPERPARATHYROIDISM SURGERY

Yildiz R., Şan H., ALAGÖZ E.

Acta Endocrinologica , cilt.18, sa.3, ss.316-323, 2022 (SCI-Expanded, Scopus)

8. Correlation of Morphological and Functional Cardiac Images: Fusion of Myocardial Perfusion SPECT and CT Angiography Morfolojik ve Fonksiyonel Kardiyak Görüntülerin Korelasyonu: Miyokard Perfüzyon SPECT ve BT Anjiyografi Füzyonu

Şan H., KARAÇALIOĞLU A. Ö., BOZLAR U., İNCE S., ALAGÖZ E., Emer M. Ö., et al.

Molecular Imaging and Radionuclide Therapy , cilt.31, sa.2, ss.89-95, 2022 (Scopus, TRDizin)

9. Yttrium-90 (Y-90) resin microsphere therapy for patients with unresectable hepatocellular carcinoma. Identification of successful treatment response predictors and patient selection

ARSLAN N., İNCE S., OKUYUCU K., ŞAN H., ALAGÖZ E., KARADURMUŞ N., et al.

Annali Italiani di Chirurgia , cilt.92, sa.6, ss.623-631, 2021 (SCI-Expanded, Scopus)

10. Prognostic risk factors for rare oncocytic variant in 101 cases of papillary thyroid carcioma

ALAGÖZ E., OKUYUCU K., İNCE S., Mahmudov S., Ayan A., Demirci I., et al.

Hellenic Journal of Nuclear Medicine , cilt.22, sa.2, ss.116-122, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

11. Evaluation of predictor variables of diagnostic [18F] FDG-PET/CT in fever of unknown origin

OKUYUCU K., ALAGÖZ E., Demirbas S., İNCE S., Karakas A., KARAÇALIOĞLU A. Ö., et al.

Quarterly Journal of Nuclear Medicine and Molecular Imaging , cilt.62, sa.3, ss.313-320, 2018 (SCI-Expanded, Scopus)

12. Complementary role of parathormone washout test to 99m Tc-MIBI parathyroid scintigraphy and histopathologic analysis of cell types in parathyroid adenomas Gammagrafía paratiroidea con 99m Tc-MIBI: valor complementario de la paratohormona en el aspirado y análisis histopatológico de los tipos de células en los adenomas paratiroideos

İNCE S., Emer O., Deveci S., OKUYUCU K., ALAGÖZ E., San H., et al.

Revista Espanola de Medicina Nuclear e Imagen Molecular , cilt.37, sa.4, ss.205-210, 2018 (SCI-Expanded, Scopus)

13. Utility of FDGPET/CT in themanagement of primary testicular lymphoma Primer testis lenfomasında FDG PET/BT’nin yararlılığının değerlendirilmesi

OKUYUCU K., İNCE S., ALAGÖZ E., ATAŞ E., Arslan N.

Molecular Imaging and Radionuclide Therapy , cilt.27, sa.2, ss.61-65, 2018 (Scopus, TRDizin)

14. Angiographic results of the patients with positive transient ischemic dilatation on their gated myocardial perfusion imaging scans

İNCE S., KARAÇALIOĞLU A. Ö., Şan H., Emer Ö., ALAGÖZ E., YILDIRIM E., et al.

Gulhane Medical Journal , cilt.60, sa.2, ss.37-41, 2018 (Scopus, TRDizin)

15. Utility of FDG-PET/CT in primary central nervous system lymphoma and its contribution to prognosis estimation

OKUYUCU K., ALAGÖZ E.

Gulhane Medical Journal , cilt.59, sa.2, ss.44-48, 2018 (Scopus, TRDizin)

16. Can metabolic tumor parameters on primary staging 18F-FDG PET/CT aid in risk stratification of primary central nervous system lymphomas for patient management as a prognostic model? ¿Pueden contribuir los parámetros tumorales metabólicos, establecidos mediante 18F-FDG PET/TC para estadificación primaria, a la estratificación del riesgo de los linfomas del sistema nervioso central, para el tratamiento del paciente como modelo pronóstico?

OKUYUCU K., ALAGÖZ E., İNCE S., Ozaydin S., Arslan N.

Revista Espanola de Medicina Nuclear e Imagen Molecular , cilt.37, sa.1, ss.9-14, 2018 (SCI-Expanded, Scopus)

17. Assessment of risk factors in metastatic/recurrent tall cell variant of papillary thyroid carcinoma

OKUYUCU K., ALAGÖZ E., İNCE S., Arslan N.

Endokrynologia Polska , cilt.68, sa.6, ss.623-630, 2017 (SCI-Expanded, Scopus)

18. Uptake patterns of untreated primary gastrointestinal extranodal lymphomas on initial staging 18F-FDG PET/CT and metabolic tumor parameters Primer ekstranodal gastrointestinal sistem lenfomalarında primer evreleme 18F-FDG PET/BT’de tutulum paternleri ve metabolik tümör parametreleri

ALAGÖZ E., OKUYUCU K., İNCE S., Kantarcıoğlu M., Özaydın Ş., Heper C., et al.

Molecular Imaging and Radionuclide Therapy , cilt.26, sa.3, ss.83-92, 2017 (Scopus, TRDizin)

19. Yttrium-90 (Y-90) Resin Microsphere Therapy for Patients with Unresectable Hepatocellular Carcinoma: a Single-Center Experience

İNCE S., Karaman B., ALAGÖZ E., KARADURMUŞ N., Şan H., ERÇİN C. N., et al.

Journal of gastrointestinal cancer , cilt.48, sa.3, ss.281, 2017 (Scopus)

20. Prognostic importance of metabolic tumor parameters on initial FDG-PET/CT in patients with isolated infradiaphragmatic Hodgkin’s lymphoma Prognostički značaj metaboličkih tumorskih parametara na inicijalnom FDG-PET/CT kod bolesnika sa izolovanim infradijafragmalnim Hočkinovim limfomom

ALAGÖZ E., OKUYUCU K., İNCE S., Ozgur G., ÖZTÜRK M., KARAÇALIOĞLU A. Ö., et al.

Vojnosanitetski Pregled , cilt.74, sa.8, ss.728-735, 2017 (SCI-Expanded, Scopus)

21. Impact of tall cell variant histology on predicting relapse and changing the management of papillary thyroid carcinoma patients

GÜNALP B., OKUYUCU K., İNCE S., Ayan A., ALAGÖZ E.

Hellenic Journal of Nuclear Medicine , cilt.20, sa.2, ss.122-127, 2017 (SCI-Expanded, Scopus)

22. Clinical significance of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in the follow-up of colorectal cancer: Searching off approaches increasing specificity for detection of recurrence

İNCE S., OKUYUCU K., Hancerliogullarl O., ALAGÖZ E., San H., Arslan N.

Radiology and Oncology , cilt.51, sa.4, ss.378-385, 2017 (SCI-Expanded, Scopus)

23. The correlation between pre-treatment fluorodeoxyglucose positron emission tomography/computed tomography parameters and clinical prognostic factors in pediatric Hodgkin lymphoma Pediatrik Hodgkin Lenfoma Hastalarında Tedavi Öncesi Florodeoksiglukoz Pozitron Emisyon Tomografi/Bilgisayarlı Tomografi Parametreleri ve Klinik Prognostik Faktörler Arasındaki İlişki

TATCI E., Biner İ. U., Emir S., Tanyıldız H. G., ÖZMEN Ö., ALAGÖZ E., et al.

Molecular Imaging and Radionuclide Therapy , cilt.26, sa.1, ss.9-16, 2017 (Scopus, TRDizin)

24. Prognosis estimation under the light of metabolic tumor parameters on initial FDG-PET/CT in patients with primary extranodal lymphoma

OKUYUCU K., Ozaydln S., ALAGÖZ E., Ozgur G., İNCE S., Oysul F. G., et al.

Radiology and Oncology , cilt.50, sa.4, ss.360-369, 2016 (SCI-Expanded, Scopus)

25. An unusual presentation of primary hyperparathyroidism: multiple brown tumors and coexisting thyroid carcinoma Presentación inusual de hiperparatiroidismo primario: múltiples tumores pardos y coexistencia de carcinoma tiroideo

Basaran Y., İNCE S., ALAGÖZ E., MERİÇ C., Taslipinar A.

Revista Espanola de Medicina Nuclear e Imagen Molecular , cilt.35, sa.5, ss.321-324, 2016 (SCI-Expanded, Scopus)

26. Risk factors and stratification for recurrence of patients with differentiated thyroid cancer, elevated thyroglobulin and negative I-131 whole-body scan, by restaging 18F-FDG PET/CT

OKUYUCU K., İNCE S., ALAGÖZ E., Emer O., San H., Balkan E., et al.

Hellenic Journal of Nuclear Medicine , cilt.19, sa.3, ss.208-217, 2016 (SCI-Expanded, Scopus)

27. Complete remission on 18-fluorodeoxyglucose positron emission tomography/computed tomography after nivolumab treatment in a patient with indolent hodgkin lymphoma

ALAGÖZ E., İNCE S., OKUYUCU K., Ayan A., San H., KARADURMUŞ N.

Translational Cancer Research , cilt.5, sa.3, ss.320-323, 2016 (SCI-Expanded, Scopus)

28. Thyrotropinoma with Graves' disease detected by the fusion of indium-111 octreotide scintigraphy and pituitary magnetic resonance imaging

OKUYUCU K., ALAGÖZ E., Arslan N., Taslipinar A., Deveci M. S., Bolu E.

Indian Journal of Nuclear Medicine , cilt.31, sa.2, ss.141-143, 2016 (Scopus)

29. Primary sacral lymphoma initally supposed to be sacroiliitis on bone scintigrapy

OKUYUCU K., ALAGÖZ E., Özaydin Ş., Güzelkücük Ü., Arslan N.

Gulhane Medical Journal , cilt.58, sa.3, ss.327-328, 2016 (Scopus, TRDizin)

30. The widespread metastases at presentation in a patient with tall cell variant of papillary thyroid carcinoma: A case report and review of the literature

İNCE S., ALAGÖZ E., Emer M. Ö., KARSLIOĞLU Y.

Gulhane Medical Journal , cilt.58, sa.1, ss.111-114, 2016 (Scopus, TRDizin)

31. The potential value of volume-based quantitative PET parameters and increased bone marrow uptake for the prediction of survival in patients with malignant pleural mesothelioma

ÖZMEN Ö., Koyuncu A., KÖKSAL D., TATCI E., ALAGÖZ E., DEMİRAĞ F., et al.

Nuclear Medicine Communications , cilt.37, sa.1, ss.43-49, 2016 (SCI-Expanded, Scopus)

32. Clinicopathologic features and prognostic factors of tall cell variant of papillary thyroid carcinoma: Comparison with classic variant of papillary thyroid carcinoma

OKUYUCU K., ALAGÖZ E., Arslan N., Emer O., İNCE S., Deveci S., et al.

Nuclear Medicine Communications , cilt.36, sa.10, ss.1021-1025, 2015 (SCI-Expanded, Scopus)

33. 18F-FDG PET/CT findings in a case of a semantic variant of primary progressive aphasia

İNCE S., Guzeldemir E., KARAÇALIOĞLU A. Ö., Emer O., ALAGÖZ E.

Hellenic Journal of Nuclear Medicine , cilt.18, sa.2, ss.163-165, 2015 (SCI-Expanded, Scopus)

34. Evaluation of radiographic and metabolic changes in bone metastases in response to systemic therapy with18FDG-PET/CT

GÜNALP B., Oner A. O., İNCE S., ALAGÖZ E., Ayan A., Arslan N.

Radiology and Oncology , cilt.49, sa.2, ss.115-120, 2015 (SCI-Expanded, Scopus)

35. Comparison of the parameters of left ventricular systolic and diastolic functions derived from two different scintigraphic modalities Iki farkli sintigrafik modalite ile elde edilen sol ventrikül fonksiyonlarinin karşilaştirilmasi

KARAÇALIOĞLU A. Ö., Emer Ö., İNCE S., ALAGÖZ E.

Gulhane Medical Journal , cilt.57, sa.3, ss.269-273, 2015 (Scopus, TRDizin)

36. The increased risk of globus pharyngeus in patients with chronic thyroiditis: A case control study

Karahatay S., Ayan A., Aydin U., İNCE S., Emer O., ALAGÖZ E.

European Review for Medical and Pharmacological Sciences , cilt.19, sa.24, ss.4722-4727, 2015 (SCI-Expanded, Scopus)

37. Comparison of left ventricular functional parameters calculated by automatic and semi-automatic analysis in MUGA MUGA Görüntülerinde otomatik ve yariotomatik analiz ile hesaplanan sol ventrikül fonksiyonel parametre sonuçlarinin karsilastirilmasi

KARAÇALIOĞLU A. Ö., İNCE S., Emer ö., ALAGÖZ E.

Gulhane Medical Journal , cilt.56, sa.3, ss.159-163, 2014 (Scopus, TRDizin)

38. The relationship of the BRAFV600E mutation and the established prognostic factors in papillary thyroid carcinomas

Kurt B., YalçIn S., ALAGÖZ E., KARSLIOĞLU Y., YİĞİT N., GÜNAL A., et al.

Endocrine Pathology , cilt.23, sa.3, ss.135-140, 2012 (SCI-Expanded, Scopus)

39. Clinical impact of 18F-FDG PET/CT on initial staging and therapy planning for breast cancer

GÜNALP B., İNCE S., KARAÇALIOĞLU A. Ö., Ayan A., Emer O., ALAGÖZ E.

Experimental and Therapeutic Medicine , cilt.4, sa.4, ss.693-698, 2012 (SCI-Expanded, Scopus)

40. Selective intraarterial radionuclide radiotherapy of inoperable liver metastases with Yttrium-90 (Y-90) labeled microspheres in a patient with medullary thyroid carcinoma metastasis in the liver: First national administration Med̈ller tiroid kanserli bir olguda inoperabl karaciǧer metastazlarinin Yttrium-90 (Y-90) işaretli mikroküreler ile selektif intraarteriyel radyon̈klid tedavisi: Ilk ulusal uygulama

Arslan N., Üstünsöz B., ALAGÖZ E., Uǧurel Ş., Öztürk E., Tufan T., et al.

Gulhane Medical Journal , cilt.54, sa.1, ss.57-61, 2012 (Scopus, TRDizin)

41. Complete disappearance of uptake of FDG in the multifocal liver hemangioendothelioma after radioembolization therapy using yttrium-90 microspheres

Karaman B., Battal B., ALAGÖZ E., Akgun V., Ince S., Ustunsoz B.

Annals of Nuclear Medicine , cilt.26, sa.5, ss.440-443, 2012 (SCI-Expanded, Scopus)

42. Evaluation of outcome prediction and disease extension by quantitative 2-deoxy-2-[ 18F] fluoro-D-glucose with positron emission tomography in patients with small cell lung cancer

Arslan N., TUNCEL M., Kuzhan O., ALAGÖZ E., Budakoglu B., Ozet A., et al.

Annals of Nuclear Medicine , cilt.25, sa.6, ss.406-413, 2011 (SCI-Expanded, Scopus)

43. Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for hepatic neuroendocrine metastases: Initial experience at a single center Selektivno intraararterijsko radionuklidno lecenje primenom mikrosfera sa itrijumom-90 kod neuroendokrinih metastaza u jetri: Prvo iskustvo u jednom centru

Arslan N., Emi M., ALAGÖZ E., Üstünsöz B., Oysul K., Arpaci F., et al.

Vojnosanitetski Pregled , cilt.68, sa.4, ss.341-348, 2011 (SCI-Expanded, Scopus)

44. Combination of preoperative ultrasonographic mapping and radioguided occult lesion localization in patients with locally recurrent/persistent papillary thyroid carcinoma: A practical method for central compartment reoperations

ILGAN S., Öztürk E., Yildiz R., Emer Ö., Ayan A., Görgülü S., et al.

Clinical Nuclear Medicine , cilt.35, sa.11, ss.847-852, 2010 (SCI-Expanded, Scopus)

45. The role of 18f-fluoro-2-deoxyglucose positron emission tomography imaging in thyroid cancers Tiroid kanserlerinde flor-18 florodeoksiglukoz pozitron emisyon tomografi görüntülemenin yeri

Emer M. Ö., ILGAN S., ALAGÖZ E., Arslan N., KARAÇALIOĞLU A. Ö., GÜNALP B., et al.

Gulhane Medical Journal , cilt.51, sa.4, ss.229-234, 2009 (Scopus, TRDizin)

46. Thyroid medullary carcinoma in a teenager with Cowden syndrome

Koksal Y., Sahin M., Koksal H., ORHAN D., Unal E., ALAGÖZ E.

Laryngoscope , cilt.117, sa.7, ss.1180-1182, 2007 (SCI-Expanded, Scopus)

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Proje

Tez Danışmanlığı

Açık Erişim